No Data
No Data
Huangshan Capsule: Report for the first quarter of 2025
Huangshan Capsule: 2024 Annual Report Summary
Huangshan Capsule: 2024 Annual Report
Anhui Huangshan Capsule (002817.SZ): The net income for the fiscal year 2024 is 49.2534 million yuan, and a dividend of 0.38 yuan per share is proposed.
On March 28, Gelonghui announced that Anhui Huangshan Capsule (002817.SZ) released its 2024 annual report, achieving revenue of 0.473 billion yuan in 2024, a year-on-year increase of 2.31%; the net income attributable to shareholders of the listed company was 49.2534 million yuan, a year-on-year decrease of 24.07%; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 47.1563 million yuan, a year-on-year decrease of 24.14%; the basic EPS was 0.16 yuan; it is proposed to distribute a cash dividend of 0.38 yuan (including tax) for every 10 shares to all shareholders.
Anhui Huangshan Capsule (002817.SZ): No information has been received regarding the controlling Shareholder's plans for restructuring or asset injection.
On March 17, Gelonghui reported that Anhui Huangshan Capsule (002817.SZ) stated on the investor interaction platform that the company's main Business is the research, development, production, and sales of hollow capsules. As of now, the company has not been informed of any plans for restructuring or asset injection by the controlling Shareholder. If there are any related matters, the company will strictly comply with relevant requirements and fulfill information disclosure obligations in a timely manner.
Anhui Huangshan Capsule (002817.SZ) intends to distribute 0.27 yuan for every 10 shares, with the ex-rights and ex-dividend date on January 7.
Anhui Huangshan Capsule (002817.SZ) announced that the proposed equity distribution for the first three quarters of 2024 is: to distribute to all Shareholders according to...